Annual Drug Patent Expirations for YAZ
Yaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for YAZ.
This drug has sixty-seven patent family members in thirty-eight countries.
The generic ingredient in YAZ is drospirenone; ethinyl estradiol. Two suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
